These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21172283)

  • 1. Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT II.
    Felley C; Vader JP; Juillerat P; Pittet V; O'Morain C; Panis Y; Vucelic B; Gonvers JJ; Mottet C; Froehlich F; Michetti P;
    J Crohns Colitis; 2009 Dec; 3(4):250-6. PubMed ID: 21172283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT II.
    Mottet C; Vader JP; Felley C; Froehlich F; Gonvers JJ; Juillerat P; Stockbrügger R; Angelucci E; Seibold F; Michetti P; Pittet V;
    J Crohns Colitis; 2009 Dec; 3(4):257-63. PubMed ID: 21172284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriate treatment for Crohn's disease: methodology and summary results of a multidisciplinary international expert panel approach--EPACT.
    Vader JP; Froehlich F; Juillerat P; Burnand B; Felley C; Gonvers JJ; Mottet C; Pittet V; Dubois RW; Wietlisbach V; Michetti P
    Digestion; 2006; 73(4):237-48. PubMed ID: 16940727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT II.
    Juillerat P; Vader JP; Felley C; Pittet V; Gonvers JJ; Mottet C; Bemelman WA; Lémann M; Oresland T; Michetti P; Froehlich F;
    J Crohns Colitis; 2009 Dec; 3(4):241-9. PubMed ID: 21172282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriateness.
    Juillerat P; Pittet V; Vader JP; Burnand B; Gonvers JJ; de Saussure P; Mottet C; Seibold F; Rogler G; Sagmeister M; Felley C; Michetti P; Froehlich F;
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1352-7. PubMed ID: 20964261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT II.
    Michetti P; Stelle M; Juillerat P; Gassull M; Heil FJ; Stange E; Mottet C; Gonvers JJ; Pittet V; Vader JP; Froehlich F; Felley C;
    J Crohns Colitis; 2009 Dec; 3(4):232-40. PubMed ID: 21172281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel.
    Pittet V; Froehlich F; Maillard MH; Mottet C; Gonvers JJ; Felley C; Vader JP; Burnand B; Michetti P; Schoepfer A;
    J Crohns Colitis; 2013 Nov; 7(10):820-6. PubMed ID: 23664620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic and medical management of fibrostenotic Crohn's disease.
    Thienpont C; Van Assche G
    Dig Dis; 2014; 32 Suppl 1():35-8. PubMed ID: 25531351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating appropriateness of treatment for Crohn's disease: feasibility of an explicit approach.
    Guessous I; Juillerat P; Pittet V; Froehlich F; Burnand B; Mottet C; Felley C; Michetti P; Vader JP
    Digestion; 2007; 75(1):46-52. PubMed ID: 17429207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.
    Hlavaty T; Pierik M; Henckaerts L; Ferrante M; Joossens S; van Schuerbeek N; Noman M; Rutgeerts P; Vermeire S
    Aliment Pharmacol Ther; 2005 Oct; 22(7):613-26. PubMed ID: 16181301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T; Göke B; Sackmann M
    Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of fibrostenotic and fistulizing Crohn's disease.
    Schoepfer AM; Safroneeva E; Vavricka SR; Peyrin-Biroulet L; Mottet C
    Digestion; 2012; 86 Suppl 1():23-7. PubMed ID: 23051723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPACT II: project and methods.
    Juillerat P; Froehlich F; Felley C; Pittet V; Mottet C; Gonvers JJ; Michetti P; Vader JP
    Digestion; 2007; 76(2):84-91. PubMed ID: 18239398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage surgery after failure of endoscopic balloon dilatation versus surgery first for ileocolonic anastomotic stricture due to recurrent Crohn's disease.
    Li Y; Stocchi L; Shen B; Liu X; Remzi FH
    Br J Surg; 2015 Oct; 102(11):1418-25; discussion 1425. PubMed ID: 26313750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of need for surgery after endoscopic balloon dilation of ileocolic anastomotic stricture in patients with Crohn's disease.
    Lian L; Stocchi L; Shen B; Liu X; Ma J; Zhang B; Remzi F
    Dis Colon Rectum; 2015 Apr; 58(4):423-30. PubMed ID: 25751799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: a guideline for primary care physicians from the National Stroke Association work group on recurrent stroke prevention.
    Hanley D; Gorelick PB; Elliott WJ; Broder MS; Saver JL; Kidwell CS; Fagan SC; Wilson A; Lennihan L; Schwer WA; Rubenstein LZ; Crowell RM; Haines SJ; Lopez CC; Zorowitz R; Dubois RW
    J Stroke Cerebrovasc Dis; 2004; 13(5):196-207. PubMed ID: 17903976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcomes of Surgery Versus Endoscopic Balloon Dilation for Stricturing Crohn's Disease.
    Greener T; Shapiro R; Klang E; Rozendorn N; Eliakim R; Ben-Horin S; Amitai MM; Kopylov U
    Dis Colon Rectum; 2015 Dec; 58(12):1151-7. PubMed ID: 26544812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: Medical therapy for fistulizing Crohn's disease.
    Bressler B; Sands BE
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1283-93. PubMed ID: 17059510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians.
    Sandborn WJ; Hanauer SB
    Am J Gastroenterol; 2002 Dec; 97(12):2962-72. PubMed ID: 12492177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.